The presence of quiescent CML LSCs [8,9] which are not reliant on BCR/ABL activity for survival [2,10] has been proposed as the reason why CML is resistant to TKIs [11]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.